Literature DB >> 12953841

Chemistry and biology of angiitis inducer, Candida albicans water-soluble mannoprotein-beta-glucan complex (CAWS).

Naohito Ohno1.   

Abstract

Deep mycoses have been clearly demonstrated to release beta-glucans into the blood. Structure of the beta-glucan was, at least in part, suggested to be a mannoprotein beta-glucan complex (CAWS) as assessed by biochemical and immunochemical analyses of the extracellular macromolecular fraction of Candida albicans. Half clearance time of i.v. administered CAWS was about 30 min in mice. In addition to the reactivity with limulus G-test, CAWS was found to exhibit various biological activities, such as cytokine synthesis by leukocyte, platelet aggregation, lethal toxicity, enhancement of side effect of indomethacin, induction of coronary arteritis in mice, and so on. In this review, the chemical properties and biological activities of CAWS are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12953841     DOI: 10.1111/j.1348-0421.2003.tb03409.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  13 in total

1.  Diagnostic potential of antibody titres against Candida cell wall β-glucan in Kawasaki disease.

Authors:  K Ishibashi; R Fukazawa; N N Miura; Y Adachi; S Ogawa; N Ohno
Journal:  Clin Exp Immunol       Date:  2014-07       Impact factor: 4.330

2.  Improved detection of deeply invasive candidiasis with DNA aptamers specific binding to (1→3)-β-D-glucans from Candida albicans.

Authors:  X-L Tang; Y Hua; Q Guan; C-H Yuan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-25       Impact factor: 3.267

Review 3.  Applications of polymeric adjuvants in studying autoimmune responses and vaccination against infectious diseases.

Authors:  Akhilesh Kumar Shakya; Kutty Selva Nandakumar
Journal:  J R Soc Interface       Date:  2013-02       Impact factor: 4.118

4.  The involvement of the vasa vasorum in the development of vasculitis in animal model of Kawasaki disease.

Authors:  Akiko Hamaoka-Okamoto; Chinatsu Suzuki; Tomoyo Yahata; Kazuyuki Ikeda; Noriko Nagi-Miura; Naohito Ohno; Yoshinori Arai; Hideo Tanaka; Tetsuro Takamatsu; Kenji Hamaoka
Journal:  Pediatr Rheumatol Online J       Date:  2014-03-30       Impact factor: 3.054

Review 5.  Kawasaki disease: pathophysiology and insights from mouse models.

Authors:  Magali Noval Rivas; Moshe Arditi
Journal:  Nat Rev Rheumatol       Date:  2020-05-26       Impact factor: 20.543

6.  A Model of Left Ventricular Dysfunction Complicated by CAWS Arteritis in DBA/2 Mice.

Authors:  Naoto Hirata; Ken-Ichi Ishibashi; Tatsuya Usui; Jiro Yoshioka; Satoru Hata; Yoshiyuki Adachi; Noriko Nagi-Miura; Shin Ohta; Naohito Ohno
Journal:  Int J Vasc Med       Date:  2012-07-08

7.  CDCP1 on Dendritic Cells Contributes to the Development of a Model of Kawasaki Disease.

Authors:  Yu Lun; Nozha Borjini; Noriko N Miura; Naohito Ohno; Nora G Singer; Feng Lin
Journal:  J Immunol       Date:  2021-06-07       Impact factor: 5.426

8.  Characterization and partial purification of Candida albicans Secretory IL-12 Inhibitory Factor.

Authors:  Mingyue Wang; Pranab K Mukherjee; Jyotsna Chandra; Ali Abdul Lattif; Thomas S McCormick; Mahmoud A Ghannoum
Journal:  BMC Microbiol       Date:  2008-02-19       Impact factor: 3.605

9.  CAWS administration increases the expression of interferon γ and complement factors that lead to severe vasculitis in DBA/2 mice.

Authors:  Noriko Nagi-Miura; Daisuke Okuzaki; Kosuke Torigata; Minami A Sakurai; Akihiko Ito; Naohito Ohno; Hiroshi Nojima
Journal:  BMC Immunol       Date:  2013-09-24       Impact factor: 3.615

Review 10.  Innate Immune and Fungal Model of Alzheimer's Disease.

Authors:  Bodo Parady
Journal:  J Alzheimers Dis Rep       Date:  2018-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.